Cardinal Health Surges to 223rd in Trading Volume with $489 Million Turnover

On April 30, 2025, Cardinal Health (CAH) saw a significant increase in trading volume, with a turnover of $489 million, marking a 66.25% rise from the previous day. This surge placed Cardinal Health at the 223rd position in terms of trading volume for the day. The stock price of Cardinal Health has been on a steady upward trajectory, rising by 1.04% and marking its seventh consecutive day of gains, with a cumulative increase of 7.72% over the past week.

Cardinal Health is scheduled to release its third-quarter earnings on May 1, 2025. Analysts anticipate a 14.4% increase in earnings per share (EPS) to $2.15, driven by a projected 5.8% rise in revenue to $55.31 billion. The company's recent strategic acquisitions, such as the integration of Integrated Oncology Network (ION) into its Navista platform and the majority acquisition of GI Alliance (GIA), are expected to bolster its Pharmaceutical and Specialty Solutions segment. These moves align with Cardinal Health's broader strategy to enhance patient care and strengthen its specialty services.

Despite the positive outlook, the company may face challenges due to the expiration of a key customer contract, which could partially offset the gains from these acquisitions. However, the full benefits of these strategic moves are expected to materialize more prominently toward the end of the fiscal year. Additionally, the company's long-term EPS growth target of 10-14% reflects optimism about its future performance, as indicated by the recent all-time high stock price of $140.69.